However, Jiang et al. [35] found that excessive expression of IL-22 during chronic hepatitis and hepatocellular carcinomas (HCCs) may allow survival of damaged hepatocytes that are precursors for HCCs, thereby promoting cancer. The gene discussed is IL22; the disease is chronic hepatitis.